Trials / Sponsors / Guard Therapeutics AB
Guard Therapeutics AB
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery Kidney Injury Following Open-Chest Cardiac Surgery | Phase 2 | 2024-08-26 |
| Terminated | Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac S Acute Kidney Injury | Phase 2 | 2022-03-31 |
| Completed | A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery Acute Kidney Injury (AKI) | Phase 1 | 2021-03-16 |